Arcadia Biosciences, Inc.
RKDA· Nasdaq
Released Mar 28, 2024, after the close
10-K filed Mar 28, 2024, 88 days after period end · 0000950170-24-038176
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | $627.00K | — | $2.17M | $7.13M |
| Net Income | -$2.85M |
Arcadia Biosciences, Inc. · CIK 1469443 · Engraved from SEC EDGAR
| -$4.24M |
| -$9.28M |
| $8.90M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.